Alternative splicing in ovarian cancer
Abstract Ovarian cancer is the second leading cause of gynecologic cancer death worldwide, with only 20% of cases detected early due to its elusive nature, limiting successful treatment. Most deaths occur from the disease progressing to advanced stages. Despite advances in chemo- and immunotherapy,...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
BMC
2024-10-01
|
| Schriftenreihe: | Cell Communication and Signaling |
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1186/s12964-024-01880-8 |